Need for a guideline on the clinical development of thrombopoetin receptor agonists for the treatment of chronic immune (idiopathic) thrombocytopenic purpura - Scientific guideline

HumanScientific guidelines

Polish is available via eTranslation, the European Commission's machine translation service.

Translate to Polish | Important information about machine translation

This document reflects the need for a guideline on the evaluation of the safety and efficacy of thrombopoetin receptor agonists fin the treatment of chronic immune (idiopathic) thrombocytopenic purpura.

Keywords: Chronic immune idiopathic thrombocytopenic purpura, ITP, thrombopoeting agonists

Current effective version

Concept paper on the need for a guideline on the clinical development of thrombopoetin receptor agonists for the treatment of chronic immune (idiopathic) thrombocytopenic purpura

Draft: consultation closed Consultation dates: to Reference Number: EMA/CHMP/EWP/203111/2010

English (EN) (103.52 KB - PDF)

Opublikowane po raz pierwszy: Ostatnia aktualizacja:
Zobacz

Share this page